Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
297,985,865
-
Share change
-
-10,470,882
-
Total reported value
-
$11,216,261,663
-
Put/Call ratio
-
74%
-
Price per share
-
$37.64
-
Number of holders
-
819
-
Value change
-
-$400,087,020
-
Number of buys
-
301
-
Number of sells
-
411
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q3 2020
As of 30 Sep 2020,
GLAXOSMITHKLINE PLC - ADR (GSK) was held by
819 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
297,985,865 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, Fisher Asset Management, LLC, ROYAL BANK OF CANADA, STATE STREET CORP, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, and Black Creek Investment Management Inc..
This page lists
819
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.